Cargando…

Acute Myocardial Infarction in Patients with Hereditary Thrombophilia—A Focus on Factor V Leiden and Prothrombin G20210A

Factor V (FV) Leiden and prothrombin G20210A are the most common hereditary thrombophilias. While their role in venous thromboembolism is well known, there are still uncertainties regarding their relationship with arterial thrombotic events, especially coronary ones. Our research, based on an in-dep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badescu, Minerva Codruta, Butnariu, Lăcrămioara Ionela, Costache, Alexandru Dan, Gheorghe, Liliana, Seritean Isac, Petronela Nicoleta, Chetran, Adriana, Leancă, Sabina Andreea, Afrăsânie, Irina, Duca, Ștefania-Teodora, Gorduza, Eusebiu Vlad, Costache, Irina Iuliana, Rezus, Ciprian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300874/ https://www.ncbi.nlm.nih.gov/pubmed/37374153 http://dx.doi.org/10.3390/life13061371

Ejemplares similares

Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?
por: Butnariu, Lăcrămioara Ionela, et al.
Publicado: (2022)

Ischemia with Nonobstructive Coronary Artery Disease and Atrial Cardiomyopathy—Two Sides of the Same Story?
por: Afrăsânie, Irina, et al.
Publicado: (2023)

Myocardial Ischemia Related to Common Cancer Therapy—Prevention Insights
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction
por: Leancă, Sabina Andreea, et al.
Publicado: (2023)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Could Endothelin-1 Be a Promising Neurohormonal Biomarker in Acute Heart Failure?
por: Dmour, Bianca-Ana, et al.
Publicado: (2023)

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012)

Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy
por: Popescu, Diana, et al.
Publicado: (2023)

Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
por: Elson, Sarah L., et al.
Publicado: (2020)

T-Wave Analysis on the 24 h Holter ECG Monitoring as a Predictive Assessment of Major Adverse Cardiovascular Events in Patients with Myocardial Infarction: A Literature Review and Future Perspectives
por: Duca, Ștefania-Teodora, et al.
Publicado: (2023)

Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021)

The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
por: Machado, Marcia, et al.
Publicado: (2023)

Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment
por: Leancă, Sabina Andreea, et al.
Publicado: (2022)

Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
por: Zhang, Peijin, et al.
Publicado: (2014)

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran
por: Kardi, Mohammad Taghi, et al.
Publicado: (2018)

The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis
por: Garrido-Barbero, Maria, et al.
Publicado: (2019)

Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
por: El-Ghonemy, Mohamed S., et al.
Publicado: (2020)

ECG and Biomarker Profile in Patients with Acute Heart Failure: A Pilot Study
por: Chetran, Adriana, et al.
Publicado: (2022)

Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease
por: Samarah, Fekri, et al.
Publicado: (2018)

The Genetic Architecture of the Etiology of Lower Extremity Peripheral Artery Disease: Current Knowledge and Future Challenges in the Era of Genomic Medicine
por: Butnariu, Lăcrămioara Ionela, et al.
Publicado: (2022)

Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study
por: Ahmed, Nadir A., et al.
Publicado: (2019)

Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region
por: Jadaon, Mehrez M.
Publicado: (2011)

Large‐scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population
por: Raptopoulou, Alkistis, et al.
Publicado: (2022)

The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms
por: Butnariu, Lăcrămioara Ionela, et al.
Publicado: (2022)

Myocardial Ischemia in Patients with COVID-19 Infection: Between Pathophysiological Mechanisms and Electrocardiographic Findings
por: Duca, Ștefania Teodora, et al.
Publicado: (2022)

MTHFR C677T, Prothrombin G20210A, and Factor V Leiden (G1691A) Polymorphism and Beta-Thalassemia Risk: A Meta-Analysis
por: Nigam, Nitu, et al.
Publicado: (2020)

The impact of prothrombin (G20210A) gene mutation on stroke in youths
por: Saadatnia, Mohammad, et al.
Publicado: (2012)

Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia
por: Badescu, Minerva Codruta, et al.
Publicado: (2021)

Ischemic Heart Disease in the Context of Different Comorbidities
por: Costache, Irina-Iuliana, et al.
Publicado: (2022)

Different outcome of six homozygotes for prothrombin A20210A gene variant
por: Di Micco, Pierpaolo, et al.
Publicado: (2008)

Prevalence of the prothrombin G20210A mutation among ischemic stroke patients
por: Ahmed, Salar A., et al.
Publicado: (2020)

Wolf-Hirschhorn Syndrome: Clinical and Genetic Study of 7 New Cases, and Mini Review
por: Gavril, Eva-Cristiana, et al.
Publicado: (2021)

Atherosclerosis in Patients with Congenital Hemophilia: A Focus on Peripheral Artery Disease
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome
por: Butnariu, Lăcramioara Ionela, et al.
Publicado: (2023)

Mutation in the Prothrombin Gene G20210A as a Cause of Cerebral Venous Thrombosis
por: Arroyave, Jorge A., et al.
Publicado: (2012)

Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation
por: Mirrakhimov, Aibek E., et al.
Publicado: (2012)

Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity
por: Nikolaeva, M. G., et al.
Publicado: (2021)

Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
por: John-Olabode, Sarah O, et al.
Publicado: (2021)

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ir4mcebm1tfjc692qrdvj48k1